From: A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
Reference | Dx | Sample (n) | Age (years, mean (SD) | Sex, female (%) | Illness duration | BMI (kg m−2), mean (SD) | Weight (kg), mean (SD) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CFS | HC | CFS | HC | CFS | HC | CFS | HC | CFS | HC | |||
Armstrong et al. | Canadian (2003) | 34 | 25 | 34.9 (1.8) | 33.0 (1.6) | 100% | 100% | NR | 24.0 (0.81) | 23.0 (0.74) | NR | |
Frémont et al. | Fukuda (1994) | Belgian: 18 Norwegian: 17 | Belgian: 19 Norwegian: 17 | 38.5 (13) 41 (12.5) | 41 (12.6) 45 (19) | 83% 88% | 79% 82% | Belgian: 7 ± 4 years Norwegian: 12 ± 9 years | NR | NR | ||
Giloteaux et al. | Fukuda (1994) | 49 | 39 | 50.2 (12.6) | 45.5 (9.9) | 78% | 77% | NR | 25.5 (4.9) | 27.1 (6.1) | NR | |
Mandarano et al. | Fukuda (1994) | Taxa abundance comparisons 17 Diversity subgroup 11 | Taxa abundance comparisons 17 Diversity subgroup 10 | 52 (11.9) 54 (11.6) | 44.6 (10.9) 43.6 (13.6) | 76% 64% | 94% 90% | NR | 26.8 (4.7) 26.2 (4.9) | 27.4 (4.5) 27.7 (5.2) | NR | |
Rao et al. | Canadian (2003) | CFS placebo: 16 CFS treatment: 19 | NR | 77% | NR | NR | NR | |||||
Sheedy et al. | Holmes (1988) Fukuda (1994) Candain (2003) | 108 | 177 | NR | NR | NR | NR | NR | ||||
Shukla et al. | Fukuda (1994) | 10 | 10 | 48.6 (10.5) | 46.5 (13.0) | 80% | 80% | NR | 23.9 (4.3) | 24.6 (3.3) | 68.3 (13.7) | 65.5 (8.3) |